Hampshire, United Kingdom

Richard Franklin

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Richard Franklin: Innovator in Platelet Lowering Agents

Introduction

Richard Franklin is a notable inventor based in Hampshire, GB, recognized for his contributions to the field of pharmaceuticals, particularly in the development of platelet lowering agents. With a total of three patents to his name, Franklin has made significant strides in improving patient safety and compliance in the treatment of myeloproliferative diseases.

Latest Patents

Franklin's latest patents include innovative compounds that focus on reducing platelet count. One of his key inventions is related to substituted quinazolines, which are prodrugs of 3-or 5-substituted analogues of the selective platelet lowering agent anagrelide. This invention aims to reduce cardiovascular side effects, thereby enhancing patient compliance and safety. The compounds function by inhibiting the formation of blood platelets, with one example being methyl 2-(2-amino-5,6-dichloroquinazolin-3 (4H)-yl)-2-methylpropanoate. Another patent focuses on the discovery of 3- and 5-substituted analogues of anagrelide, which also aim to improve patient outcomes by minimizing cardiovascular risks.

Career Highlights

Throughout his career, Richard Franklin has worked with prominent companies in the pharmaceutical industry, including Shire LLC and Shire Holdings AG. His work has been instrumental in advancing the understanding and treatment of conditions related to platelet formation.

Collaborations

Franklin has collaborated with notable professionals in his field, including Bernard Thomas Golding and Peter A Cicala. These collaborations have contributed to the development of his innovative patents and have furthered research in platelet lowering agents.

Conclusion

Richard Franklin's contributions to the field of pharmaceuticals, particularly in the development of safer platelet lowering agents, highlight his commitment to improving patient care. His innovative patents and collaborations reflect his significant impact on medical research and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…